AusBiotech wins grant to engage in Asia
02 July, 2013AusBiotech was among the 27 member-based business organisations that have been awarded grants to help them expand their networks in Asia. The grants were provided under the Australian Government’s inaugural Asian Century Business Engagement plan and announced by the Hon Kelvin Thomson, Parliamentary Secretary for Trade, last Friday.
Phosphagenics investigation
02 July, 2013An independent financial investigation is underway at Phosphagenics.
Carr returns to industry portfolio
02 July, 2013Kevin Rudd’s new cabinet, sworn in yesterday, will see Kim Carr return to take up the industry and innovation and higher education portfolio.
REVA Medical recruiting in A/NZ for stent trial
01 July, 2013 by Dylan Bushell-EmblingREVA Medical (ASX:RVA) has commenced recruitment for the Australia/New Zealand arm of its CE Mark trial for ReZolve 2, a bioresorbable cardiac scaffold.
Phylogica enhances peptide screening capabilities
28 June, 2013 by Dylan Bushell-EmblingPhylogica (ASX:PYC) has improved its Phylomer peptide screening platform to allow it to discover candidates that can penetrate cell walls and deliver drug cargoes to a specific target.
Global Medisafe makes it to market
27 June, 2013 by Dylan Bushell-EmblingGlobal Medisafe Holdings has launched its first Clik-Lok safety syringe product in Europe and will soon start the process of securing Australian approval.
R&D Tax Bill introduced to parliament
27 June, 2013A Bill was yesterday introduced into parliament to jointly legislate for quarterly credits for companies entitled to the refundable 45% R&D Tax Incentive and to enact the $20 billion turnover cap for companies to be eligible for the 40% non-refundable R&D tax offset, as announced as part of the government’s A Plan for Australian Jobs in February.
Biotech’s industry conference returns to Qld: early bird about to close
25 June, 2013With early-bird registrations about to close (28 June), preparations have kicked into top gear at AusBiotech as the team prepares to return the industry event of the year to Brisbane, Queensland, from 30 October-1 November 2013.
GI Dynamics gets funding for French obesity trial
21 June, 2013 by Dylan Bushell-EmblingThe French Government has agreed to fund a two-year economic impact study of GI Dynamics’ (ASX:GID) EndoBarrier Therapy in obesity and type 2 diabetes.
QBiotics launches $10m capital raising
20 June, 2013 by Dylan Bushell-EmblingQBiotics is involved in a $10m capital raising, seeking to raise funds for human studies of its anti-tumour candidate and research into the wound-healing potential of a new compound.
Grants available to partner with Massachusetts life sciences companies
20 June, 2013A new funding program has recently been announced by the State of Victoria and the Commonwealth of Massachusetts to support joint research and development (R&D) projects.
WA researchers target key plant pathogen
19 June, 2013 by Dylan Bushell-EmblingMurdoch University scientists have developed a method for using gene silencing to control root lesion nematodes - plant pathogens which cause major agricultural damage.
iSonea picks manufacturing partner for AirSonea
19 June, 2013 by Dylan Bushell-EmblingiSonea (ASX:ISN) has engaged a Hong Kong manufacturer to produce its AirSonea mobile wheeze monitoring device, ahead of the product’s Australian launch in September.
AusBiotech delegation of CEOs to Parliament House
18 June, 2013AusBiotech, its member CEOs and directors were yesterday hosted at Parliament House for this year’s CEO Forum, which was addressed by a range of speakers on innovation policy and programs, including the Hon Greg Combet, Minister for Climate Change, Industry and Innovation.
Pharmaxis presents new cystic fibrosis trial data
18 June, 2013 by Dylan Bushell-EmblingPharmaxis (ASX:PXS) said CF patients receiving Bronchitol in recent phase III trials experienced fewer exacerbations long term than the control groups.
